Long-term safety and tolerability of bimekizumab in patients with axial spondyloarthritis and psoriatic arthritis: Results from pooled phase 2b/3 studies

被引：0
|
作者：
Mease, P. J. [1 ,2 ]
Poddubnyy, D. [3 ]
Orbai, A. M. [4 ]
Warren, R. B. [5 ,6 ]
Fleurinck, C. [7 ]
Bajracharya, R. [8 ]
Ink, B. [8 ]
Massow, U. [9 ]
Shende, V [8 ]
Shepherd-Smith, J. [8 ]
Peterson, L. [10 ]
White, K. [8 ]
Landewe, R. [11 ]
Gensler, L. S. [12 ]
机构：
[1] Univ Washington, Swedish Med Ctr, Seattle, WA 98195 USA
[2] Univ Washington, Prov St Joseph Hlth, Seattle, WA 98195 USA
[3] Charite Univ Med Berlin, Dept Gastroenterol Infect Dis & Rheumatol, Berlin, Germany
[4] Johns Hopkins Univ, Sch Med, Div Rheumatol, Baltimore, MD USA
[5] Northern Care Alliance NHS Fdn Trust, Dermatol Ctr, Manchester, Lancs, England
[6] Univ Manchester, NHS Fdn Trust, NIHR Manchester Biomed Res Ctr, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England
[7] UCB Pharma, Brussels, Belgium
[8] UCB Pharma, Slough, Berks, England
[9] UCB Pharma, Monheim, Germany
[10] UCB Pharma, Morrisville, NY USA
[11] Amsterdam & Zuyderland MC, Amsterdam Rheumatol & Clin Immunol Ctr, Heerlen, Netherlands
[12] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
SWISS MEDICAL WEEKLY | 2024年 / 154卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
IP 7
引用
收藏
页码：35S / 35S
页数：1
相关论文
共 50 条
  • [11] SAFETY PROFILE OF BIMEKIZUMAB AT WEEK 16 IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS AND PSORIATIC ARTHRITIS: RESULTS FROM FOUR PLACEBO-CONTROLLED PHASE 3 STUDIES
    Poddubnyy, D.
    Gensler, L. S.
    Mease, P. J.
    Orbai, A. M.
    Warren, R. B.
    Ink, B.
    Massow, U.
    Assudani, D.
    Fleurinck, C.
    Shende, V.
    Smith, J.
    Peterson, L.
    White, K.
    Landewe, R. B. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1686 - 1687
  • [12] BIMEKIZUMAB LONG-TERM SAFETY AND EFFICACY IN PATIENTS WITH ANKYLOSING SPONDYLITIS: 3-YEAR RESULTS FROM A PHASE 2B STUDY
    Van der Heijde, D.
    Deodhar, A.
    Gensler, L. S.
    Poddubnyy, D.
    Kivitz, A.
    Dougados, M.
    De Peyrecave, N.
    Oortgiesen, M.
    Vaux, T.
    Fleurinck, C.
    Baraliakos, X.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 332 - 333
  • [13] Long-term Safety of Ixekizumab in Adult Patients with Psoriasis, Psoriatic Arthritis, and Axial Spondyloarthritis
    Deodhar, Atul
    Blauvelt, Andrew
    Schwartzman, Sergio
    Salvarani, Carlo
    Feely, Meghan
    Kronbergs, Andris
    Eberhart, Nadia
    Zhu, Danting
    Mevel, Elsa
    Holzkamper, Thorsten
    Krishnan, Eswar
    Lebwohl, Mark
    Rahman, Proton
    Marzo-Ortega, Helena
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2071 - 2074
  • [14] LONG-TERM SAFETY OF IXEKIZUMAB IN ADULT PATIENTS WITH PSORIASIS, PSORIATIC ARTHRITIS, AND AXIAL SPONDYLOARTHRITIS
    Deodhar, Atul
    Blauvelt, Andrew
    Schwartzman, Sergio
    Salvarani, Carlo
    Feely, Meghan
    Kronbergs, Andris
    Eberhart, Nadia
    Zhu, Danting
    Mevel, Elsa
    Holzkaemper, Thorsten
    Krishnan, Eswar
    Lebwohl, Mark
    Rahman, Proton
    Marzo-Ortega, Helena
    Nash, Peter
    INTERNAL MEDICINE JOURNAL, 2023, 53 : 37 - 37
  • [15] Long-term Safety of Ixekizumab in Adult Patients With Psoriasis, Psoriatic Arthritis, and Axial Spondyloarthritis
    Deodhar, Atul
    Blauvelt, Andrew
    Schwartzman, Sergio
    Salvarani, Carlo
    Feely, Meghan
    Kronbergs, Andris
    Eberhart, Nadia
    Zhu, Danting
    Mevel, Elsa
    Holzkaemper, Thorsten
    Krishnan, Eswar
    Lebwohl, Mark
    Rahman, Proton
    Marzo-Ortega, Helena
    JOURNAL OF RHEUMATOLOGY, 2023, 50 (07) : 39 - 40
  • [16] LONG-TERM SAFETY OF IXEKIZUMAB IN ADULT PATIENTS WITH PSORIASIS, PSORIATIC ARTHRITIS, AND AXIAL SPONDYLOARTHRITIS
    Deodhar, Atul
    Blauvelt, Andrew
    Schwartzman, Sergio
    Salvarani, Carlo
    Feely, Meghan
    Kronbergs, Andris
    Eberhart, Nadia
    Zhu, Danting
    Mevel, Elsa
    Holzkaemper, Thorsten
    Krishnan, Eswar
    Lebwohl, Mark
    Rahman, Proton
    Marzo-Ortega, Helena
    Bullock, Craig
    RHEUMATOLOGY, 2023, 62
  • [17] LONG-TERM SUSTAINED EFFICACY AND SAFETY OF BIMEKIZUMAB ACROSS THE FULL SPECTRUM OF AXIAL SPONDYLOARTHRITIS 2-YEAR RESULTS FROM TWO PHASE 3 STUDIES
    Baraliakos, X.
    Deodhar, A.
    van der Heijde, D.
    van den Bosch, F.
    Magrey, M.
    Maksymowych, W. P.
    Tomita, T.
    Xu, H.
    Massow, U.
    Fleurinck, C.
    Vaux, T.
    Prajapati, C.
    Shepherd-Smith, J.
    Marten, A.
    Gensler, L. S.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2024, 42 (09) : 93 - 94
  • [18] Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies
    Mease, Philip J.
    Merola, Joseph F.
    Tanaka, Yoshiya
    Gossec, Laure
    Mcinnes, Iain B.
    Ritchlin, Christopher T.
    Landewe, Robert B. M.
    Asahina, Akihiko
    Ink, Barbara
    Heinrichs, Andrea
    Bajracharya, Rajan
    Shende, Vishvesh
    Coarse, Jason
    Coates, Laura C.
    RHEUMATOLOGY AND THERAPY, 2024, 11 (05) : 1363 - 1382
  • [19] BIMEKIZUMAB LONG-TERM SAFETY IN PATIENTS WITH ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS: 3-YEAR RESULTS FROM BE AGILE AND BE ACTIVE
    Poddubnyy, D.
    Mease, P.
    Warren, R. B.
    Gensler, L. S.
    Fleurinck, C.
    Ink, B.
    Oortgiesen, M.
    Vaux, T.
    Coarse, J.
    Assudani, D.
    Bajracharya, R.
    Deodhar, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (05) : 1229 - 1231
  • [20] BIMEKIZUMAB SAFETY AND EFFICACY IN PATIENTS WITH PSORIATIC ARTHRITIS: 3-YEAR RESULTS FROM A PHASE 2B OPEN-LABEL EXTENSION STUDY
    Coates, L. C.
    Warren, R. B.
    Ritchlin, C. T.
    Gossec, L.
    Merola, J. F.
    Assudani, D.
    Coarse, J.
    Eells, J.
    Ink, B.
    Mcinnes, I.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 779 - 780
12345